[{"address1": "1140-625 Howe Street", "city": "Vancouver", "state": "BC", "zip": "V6C 2T6", "country": "Canada", "phone": "604 622 1186", "fax": "604 685 9182", "website": "https://www.bioharvest.com", "industry": "Packaged Foods", "sector": "Consumer Defensive", "longBusinessSummary": "BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Zaki  Rakib Ph.D.", "age": 64, "title": "Co-Founder, Executive Chairman & President", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 964793, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ilan  Sobel", "title": "Chief Executive Officer", "fiscalYear": 2023, "totalPay": 470223, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yochi  Hagay Ph.D.", "age": 65, "title": "Co-Founder, CTO & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ilana  Belzer Ph.D.", "age": 63, "title": "Chief Operating Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 220021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Ryan", "age": 56, "title": "VP of Investor Relations, Secretary & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 44450, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian S. Cornblatt", "title": "Chief Medical Officer & Member of Scientific Advisory Board", "fiscalYear": 2023, "totalPay": 387222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew Joseph Zrebiec", "title": "Vice President of Business Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.64, "open": 5.5, "dayLow": 5.5, "dayHigh": 5.5, "regularMarketPreviousClose": 5.64, "regularMarketOpen": 5.5, "regularMarketDayLow": 5.5, "regularMarketDayHigh": 5.5, "volume": 400, "regularMarketVolume": 400, "averageVolume": 2174, "averageVolume10days": 2950, "averageDailyVolume10Day": 2950, "bid": 5.4, "ask": 5.65, "bidSize": 40000, "askSize": 40000, "marketCap": 95302352, "fiftyTwoWeekLow": 0.001, "fiftyTwoWeekHigh": 7.38, "priceToSalesTrailing12Months": 4.9818273, "fiftyDayAverage": 5.84512, "twoHundredDayAverage": 2.000535, "currency": "USD", "enterpriseValue": 99062120, "profitMargins": -0.84841, "floatShares": 11856805, "sharesOutstanding": 17327700, "heldPercentInsiders": 0.25853002, "bookValue": 0.41, "priceToBook": 13.414635, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -16230000, "trailingEps": -1.26, "enterpriseToRevenue": 5.178, "enterpriseToEbitda": -13.732, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "CNVCF", "underlyingSymbol": "CNVCF", "shortName": "BIOHARVEST SCIENCES INC.", "longName": "BioHarvest Sciences Inc.", "firstTradeDateEpochUtc": 1610116200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f97ad5b9-9a2d-3cc3-b04f-e70b35eb419b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.5, "recommendationKey": "none", "totalCash": 5168000, "totalCashPerShare": 0.316, "ebitda": -7214000, "totalDebt": 10388000, "quickRatio": 0.748, "currentRatio": 1.035, "totalRevenue": 19130000, "debtToEquity": 154.999, "revenuePerShare": 1.331, "returnOnAssets": -0.25829, "returnOnEquity": -59.559628, "freeCashflow": -5969875, "operatingCashflow": -6525000, "revenueGrowth": 1.192, "grossMargins": 0.51438, "ebitdaMargins": -0.3771, "operatingMargins": -0.29467, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]